NKTREUR Nektar Therapeutics

held by 1 manager in Q3 2017

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	1.27%	9 mo	—	$28M	1,166,100

Search